Department of Internal Medicine, Division of Gastroenterology and Hepatology, The University of Texas Medical Branch at Galveston, Galveston, TX 77550, USA.
Department of Internal Medicine, The University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77550, USA.
Dis Mon. 2024 Jan;70(1S):101674. doi: 10.1016/j.disamonth.2023.101674. Epub 2024 Jan 6.
Behçet's disease (BD) is a rare, inflammatory vascular disorder with recurrent oral and genital aphthous ulcers, along with ocular and cutaneous manifestations. Gastrointestinal (GI) BD may involve any portion of the GI tract. However, it is commonly described in the terminal ileum, followed by the ileocecal region. Diagnosis is challenging given lack of pathognomonic tests; therefore, it is based on clinical criteria. Management of intestinal BD includes different classes of medications including corticosteroids, 5-aminosalicylic acid, immunomodulators, and anti-tumor necrosis factor alpha monoclonal antibody agents. In this review, we aim to focus on intestinal BD and provide details of clinical manifestations, diagnosis and therapeutic options of intestinal BD from gastroenterology viewpoint.
贝赫切特病(BD)是一种罕见的炎症性血管疾病,具有反复发作的口腔和生殖器阿弗他溃疡,以及眼部和皮肤表现。胃肠道(GI)BD 可累及胃肠道的任何部位。然而,它通常在末端回肠中描述,其次是回盲部。由于缺乏特征性试验,因此诊断具有挑战性;因此,它基于临床标准。肠 BD 的治疗包括不同类别的药物,包括皮质类固醇、5-氨基水杨酸、免疫调节剂和抗肿瘤坏死因子α单克隆抗体药物。在这篇综述中,我们旨在关注肠 BD ,并从胃肠病学的角度提供肠 BD 的临床表现、诊断和治疗选择的详细信息。